logo

A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Larah A.J. van der Meer, Myriam Harfterkamp, Gigi van de Loo-Neus, Monika Althaus, Saskia de Ruiter, Rogier Donders, Leo M.J. de Sonneville, Jan K. Buitelaar, Pieter J. Hoekstra, Nanda Rommelse
Title
A randomized, double-blind comparison of atomoxetine and placebo on response inhibition and interference control in children and adolescents with autism spectrum disorder and comorbid attention-deficit/hyperactivity disorder symptoms.
Journal
Journal of Clinical Psychopharmacology
Year
2013
Month
December
Volume
33
Issue
6
Page(s)
pp. 824-827.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Secondary Analysis, Randomised Trial, Placebo, Peer-Reviewed, Controlled Trial, Comparative Study
Comments
This is a secondary analysis of Harfterkamp M. et al. (2012).
Keywords
Adolescent / Secondary School Age, Atomoxetine, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Intervention, Medication, Primary / Elementary School Age, Selective Noradrenaline Re-Uptake Inhibitor

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Pages


Publications | Publications Database | Search Publications